Resultados de búsqueda - Mike R. Russell

  • Mostrando 1 - 9 Resultados de 9
Limitar resultados
  1. 1
    Interleukin-1β Promotes Skeletal Colonization and Progression of Metastatic Prostate Cancer Cells with Neuroendocrine Features

    Interleukin-1β Promotes Skeletal Colonization and Progression of Metastatic Prostate Cancer Cells with Neuroendocrine Features por Qingxin Liu, Mike R. Russell, Kristina Shahriari, Danielle L. Jernigan, Mercedes Lioni, Fernando U. Garcia, Alessandro Fatatis

    Publicado 2013
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    The functional variant rs34330 of <i>CDKN1B</i> is associated with risk of neuroblastoma

    The functional variant rs34330 of <i>CDKN1B</i> is associated with risk of neuroblastoma por Mario Capasso, Lee McDaniel, Flora Cimmino, Andrea Cirino, Daniela Formicola, Mike R. Russell, Pichai Raman, Kristina A. Cole, Sharon J. Diskin

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma

    Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma por Mike R. Russell, Kirill Levin, JulieAnn Rader, Lili T. Belcastro, Yimei Li, Daniel Martínez, Bruce Pawel, Stuart D. Shumway, John M. Maris, Kristina A. Cole

    Publicado 2012
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Rare Variants in TP53 and Susceptibility to Neuroblastoma

    Rare Variants in TP53 and Susceptibility to Neuroblastoma por Sharon J. Diskin, Mario Capasso, Maura Diamond, Derek A. Oldridge, Karina L. Conkrite, Kristopher R. Bosse, Mike R. Russell, Achille Iolascon, Hákon Hákonarson, Marcella Devoto, John M. Maris

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo

    Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo por P.W.M. Ho, Ankita Goradia, Mike R. Russell, Alistair M. Chalk, Kristi Milley, Emma Baker, Janine A. Danks, Joanne Slavin, Mannu Walia, Blessing Crimeen‐Irwin, Ross A. Dickins, T. John Martin, Carl R. Walkley

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus

    CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus por Mike R. Russell, Annalise Penikis, Derek A. Oldridge, Juan R. Alvarez‐Dominguez, Lee McDaniel, Maura Diamond, Olivia Padovan, Pichai Raman, Yimei Li, Jun S. Wei, Shile Zhang, Janahan Gnanchandran, Robert C. Seeger, Shahab Asgharzadeh, Javed Khan, Sharon J. Diskin, John M. Maris, Kristina A. Cole

    Publicado 2015
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma

    Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma por JulieAnn Rader, Mike R. Russell, Lori S. Hart, Michael S. Nakazawa, Lili T. Belcastro, Daniel Martínez, Yimei Li, Erica L. Carpenter, Edward F. Attiyeh, Sharon J. Diskin, Sunkyu Kim, Sudha Parasuraman, Giordano Caponigro, Robert W. Schnepp, Andrew Wood, Bruce Pawel, Kristina A. Cole, John M. Maris

    Publicado 2013
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma

    Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma por Lori S. Hart, JulieAnn Rader, Pichai Raman, Vandana Batra, Mike R. Russell, Matthew Tsang, Maria Gagliardi, Lucy Chen, Daniel Martínez, Yimei Li, Andrew Wood, Sunkyu Kim, Sudha Parasuraman, Scott Delach, Kristina A. Cole, Shiva Krupa, Markus Boehm, Malte Peters, Giordano Caponigro, John M. Maris

    Publicado 2016
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

    RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma por Kristina A. Cole, Jonathan H. Huggins, Michael P. LaQuaglia, Chase E. Hulderman, Mike R. Russell, Kristopher R. Bosse, Sharon J. Diskin, Edward F. Attiyeh, Rachel Sennett, Geoffrey T. Norris, Marci Laudenslager, Andrew Wood, Patrick A. Mayes, Jayanti Jagannathan, Cynthia Winter, Yaël P. Mossé, John M. Maris

    Publicado 2011
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: